ACERCA DE ESTE EPISODIO

Inglés
Estados Unidos

TRANSCRIPCIÓN 🔗

BUSCAR EPISODIOS ANTERIORES

Buscar episodios anteriores de Fractals: Life Science Conversations.

OTROS EPISODIOS EN ESTE PODCAST

With more than four decades of experience in oncology, cardiovascular imaging, ultrasound, and radioligand therapy, Dr. François Tranquart has helped shape the field of molecular imaging from both sides of the table—first as an academic physician and researcher, and later as an industry leader driv…
With more than 30 years of experience spanning global pharma, emerging biotech, and the evolving field of personalized medicine, Bracken Senior Partner Dr. David Krause has helped shape the clinical and regulatory landscape across therapeutic areas—from vaccines and anti-infectives to neuropsychiat…
Can AI help radiologists see what humans can’t—and speed up drug development in the process? In this episode of SNiPs, Dr. Ben Larimer joins Bracken CEO Dr. Colin Miller to explore how artificial intelligence and machine learning are redefining what’s possible in molecular imaging. From interpretin…
What does it take to lead successful drug development—whether at a global pharma giant or a small biotech start-up? In this episode of SNiPs, Dr. David Krause joins Bracken CEO Dr. Colin Miller to reflect on three decades of experience spanning large organizations like GSK to fast-moving start-ups.…
What if a nasal spray could switch off acute social anxiety in minutes—without systemic side effects? Shawn Singh, CEO of Vistagen, joins Fractals to explain how pherines work: odorless intranasal molecules that tap the olfactory pathway to flip specific brain circuits on and off. Highlights from t…
Descargo de responsabilidad: El podcast y el arte incluidos en esta página son de The Bracken Group, que es propiedad de su propietario y no está afiliado ni respaldado por Listen Notes, Inc.